FDA Adverse Event Injury Summary report: Y

STIMULAN RAPIDCURE

MDR report key: 21880579 · Received April 22, 2025

Report

Report Number
9617083-2025-01127
Event Type
Injury
Date Received
April 22, 2025
Date of Event
March 24, 2025
Report Date
July 25, 2025
Manufacturer
BIOCOMPOSITES LTD
Product Code
MQV
PMA / PMN Number
K141830
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
RISK MANAGER
Health Professional
N

Narratives

Description of Event or Problem · 0

THE PATIENT UNDERWENT A DAIR PROCEDURE OF A FEMORAL PLATING WHERE THE PLATE WAS COATED IN STIMULANT ON THE (B)(6). IN TOTAL 80CC WERE USED. THE SURGEON WAS REMINDED TO CHECK THE CALCIUM LEVELS OF THE PATIENT ON THE (B)(6). ON THE (B)(6) A MESSAGE WAS RECEIVED TO SAY THAT THE PATIENT DID EXPERIENCE RAISED CALCIUM LEVELS AND THEY HAD TO REMOVE THE STIMULANT IN A SEPARATE PROCEDURE AND THE PATIENT IS NOW DOING WELL.

Description of Event or Problem · 0

THE PATIENT UNDERWENT A DAIR PROCEDURE OF A FEMORAL PLATING WHERE THE PLATE WAS COATED IN STIMULAN ON THE 12TH MARCH. IN TOTAL 80CC WERE USED. THE SURGEON WAS REMINDED TO CHECK THE CALCIUM LEVELS OF THE PATIENT ON THE 13TH MARCH. ON THE 24TH MARCH A MESSAGE WAS RECEIVED TO SAY THAT THE PATIENT DID EXPERIENCE RAISED CALCIUM LEVELS AND THEY HAD TO REMOVE THE STIMULAN IN A SEPARATE PROCEDURE AND THE PATIENT IS NOW DOING WELL. DUE TO THE LACK OF PROVIDED INFORMATION, A BMR REVIEW CANNOT BE CONDUCTED. HYPERCALCEMIA IS REFERENCED IN THE IFU PROVIDED AS A POSSIBLE ADVERSE EFFECT. IT HAS BEEN CONFIRMED THAT 80C OF STIMULAN RAPID CURE (20CC X 4) WAS USED DURING THE SURGERY WHICH IS FOUR TIMES OUR HIGHEST PRODUCT SIZE THEREFORE THE RISK OF HYPERCALCEMIA WILL HAVE BEEN COMPOUNDED. A TRUE ROOT CAUSE CANNOT BE IDENTIFIED FOR THIS EVENT DUE TO THE LACK OF INFORMATION REGARDING THE PRODUCT USED AND ALSO THE PATIENT DETAILS PRIOR TO AND FOLLOWING SURGERY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1239537 STIMULAN RAPIDCURE STIMULAN MQV BIOCOMPOSITES LTD 20CC

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Hospitalization